ASTERDM - IntraDay Trade Analysis with Live Signals

Last Updated Time : 20 Dec 25, 07:02 am

IntraDay Trade Rating: 3.3

📊 Analysis: ASTERDM trades at ₹598, slightly above its DMA 200 (₹596) but below DMA 50 (₹649), showing mixed technical signals. RSI at 26.7 indicates oversold conditions, while MACD (-18.4) confirms bearish momentum. Volume (5.99L vs 5.34L avg) is supportive, showing intraday liquidity. Fundamentals appear strong with ROCE 139% and ROE 200%, but valuation is stretched (P/E 91.8 vs industry 51.8). Suitable for cautious intraday trades with tight stop-losses.

• 💹 Optimal Buy Price: ₹590–600 (near support zone)
• 🎯 Profit-Taking Levels: ₹615 (first resistance), ₹630 (next resistance)
• 🛡️ Stop-Loss: Below ₹585 (to protect against breakdown)
• ⏱️ Exit if Holding: Exit intraday if price fails to sustain above ₹590 or if RSI remains below 26 with MACD staying negative despite strong volume.

Positive

• ✅ Strong ROCE 139% and ROE 200% reflect exceptional efficiency.
• ✅ PAT growth from ₹83.8 Cr. to ₹105 Cr. in latest quarter.
• ✅ PEG ratio 0.30 indicates attractive valuation relative to growth.
• ✅ DII holding increased (+1.04%), showing domestic institutional support.

Limitation

• ⚠️ Price below DMA 50, reflecting short-term weakness.
• ⚠️ RSI oversold (26.7), showing weak momentum.
• ⚠️ MACD negative (-18.4), confirming bearish sentiment.
• ⚠️ High P/E 91.8 vs industry 51.8 indicates premium valuation.

Company Negative News

• ❌ FII holding reduced (-0.92%), showing foreign investor caution.
• ❌ Quarterly profit variance (+16.8%) is positive but modest compared to valuation multiples.

Company Positive News

• 🌟 Strong quarterly PAT growth supports fundamentals.
• 🌟 Institutional support with DII inflows.
• 🌟 Dividend yield 0.84% adds investor confidence.

Industry

• 🏗️ Industry PE at 51.8 vs ASTERDM PE 91.8 shows sector undervaluation compared to ASTERDM.
• 🏗️ Healthcare sector remains defensive, supported by consistent demand and institutional interest.

Conclusion

📌 ASTERDM is a moderate intraday candidate with strong fundamentals but weak technicals and stretched valuation. Traders may attempt scalps near ₹590–600 with profit exits around ₹615–630, while maintaining a disciplined stop-loss below ₹585.

Would you like me to extend this into a healthcare sector peer benchmarking overlay so you can compare ASTERDM against Apollo Hospitals, Fortis, and other peers for intraday rotation opportunities?